# An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

> **NCT01794234** · — · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 44 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01794234
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794234, "An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01794234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*